Literature DB >> 27488494

Inter-relation between brain-derived neurotrophic factor and antioxidant enzymes in bipolar disorder.

Rodrigo B Mansur1,2, Camila M Santos1, Lucas B Rizzo1,3, Graccielle R Cunha1, Elson Asevedo1, Mariane N Noto1,4, Mariana Pedrini1, Maiara Zeni1, Quirino Cordeiro5, Roger S McIntyre2, Elisa Brietzke1.   

Abstract

OBJECTIVES: Accumulating evidence indicates that oxidative stress and neurotrophins have a bidirectional relationship. In this post hoc, exploratory analysis, we investigated the association between plasma brain-derived neurotrophic factor (BDNF) levels and activities of the antioxidant enzymes glutathione peroxidase (GPx) and superoxide dismutase (SOD) in individuals with bipolar disorder (BD) and healthy controls.
METHODS: We measured plasma levels of BDNF and activities of GPx and SOD in individuals with BD (n=59) and healthy controls (n=26). Information related to current and past psychiatric/medical history, as well as to metabolic comorbidities, was also reported.
RESULTS: There were negative correlations between BDNF, GPx (r=-.449, P≤.001) and GPx/SOD ratio (r=-.503, P<.001), and a positive correlation between BDNF and SOD (r=.254, P=.020). There was a moderating effect of body mass index (BMI) on the association between BDNF and GPx/SOD rate ratio [(RR)=1.002, P=.034]; interactions between impaired glucose metabolism (IGM), GPx (RR=1.016, P=.033), and GPx/SOD ratio (RR=1.026, P=.002) were also observed. These results were significant in models that included age, gender, alcohol, tobacco and medication use.
CONCLUSIONS: There was a robust and independent correlation between peripheral BDNF and antioxidant enzyme activities in individuals with BD, which was moderated by metabolic comorbidities. These results reinforce the concept that these systems are associated and further extend knowledge of the putative effect of metabolic comorbidities in the pathophysiological substrates of BD.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bipolar disorder; body mass index; brain-derived neurotrophic factor; diabetes; oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27488494     DOI: 10.1111/bdi.12418

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  5 in total

1.  Increased Root Canal Endotoxin Levels are Associated with Chronic Apical Periodontitis, Increased Oxidative and Nitrosative Stress, Major Depression, Severity of Depression, and a Lowered Quality of Life.

Authors:  Cinthya Gomes; Frederico Canato Martinho; Décio Sabbatini Barbosa; Leonardo Santos Antunes; Helvécio Cardoso Corrêa Póvoa; Thiago Hissnauer Leal Baltus; Nayara Rampazzo Morelli; Heber Odebrecht Vargas; Sandra Odebrecht Vargas Nunes; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

2.  Circulating Brain-Derived Neurotrophic Factor, Antioxidant Enzymes Activities, and Mitochondrial DNA in Bipolar Disorder: An Exploratory Report.

Authors:  Dong Wang; Hong Li; Xiangdong Du; Jun Zhou; Liu Yuan; Honghong Ren; Xiaonan Yang; Guangya Zhang; Xiaogang Chen
Journal:  Front Psychiatry       Date:  2020-09-11       Impact factor: 4.157

3.  Complex epigenetic patterns in cerebellum generated after developmental exposure to trichloroethylene and/or high fat diet in autoimmune-prone mice.

Authors:  Sarah J Blossom; Stepan B Melnyk; Frank A Simmen
Journal:  Environ Sci Process Impacts       Date:  2020-01-02       Impact factor: 4.238

Review 4.  Concepts of Neuroinflammation and Their Relationship With Impaired Mitochondrial Functions in Bipolar Disorder.

Authors:  Luiz Arthur Rangel Cyrino; Daniela Delwing-de Lima; Oliver Matheus Ullmann; Thayná Patachini Maia
Journal:  Front Behav Neurosci       Date:  2021-02-26       Impact factor: 3.558

Review 5.  Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress-Induced Damage in Patients with Bipolar Disorder.

Authors:  Sahithi Madireddy; Samskruthi Madireddy
Journal:  Int J Mol Sci       Date:  2022-02-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.